mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
7e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |